Skip to content
naulon

Not checkedNot checked for notices yet.

High prevalence of human bocavirus 1 in infants with lower acute respiratory tract disease in Argentina, 2007 – 2009

Lucía María Ghietto, Alicia Cámara, Yumei Zhou and 5 more

Brazilian Journal of Infectious Diseases · 2012

doi:10.1016/s1413-8670(12)70272-6 (opens in a new tab)

We email you when a new notice or a question about this paper appears.

Abstract

Human bocavirus (HBoV) is a parvovirus whose association with respiratory disease is currently under investigation. Objective: To determine HBoV prevalence in children with lower acute respiratory infection. Methods: We investigated HBoV in 433 nasopharyngeal aspirates collected in 2007–2009 from children 0 to 5 years old hospitalized with bronchiolitis or pneumonia in Córdoba, Argentina. Results: The general prevalence of HBoV was 21.5% and the positive cases (HBoV+) were more frequent during winter and spring. The mean age of HBoV+ patients was 6.9 months, with 87.1% of the detections corresponding to infants less than 1 year old (among which the prevalence of HBoV was 26.3% in patients < 3 months of age, 22.1% in 3 to 6 months, 25.3% in 6 to 9 months, and 18.8% in 9 to 12 months). The sequence analysis of the NP1 coding region of 15 isolates showed that all isolates from Cordoba were HBoV1 which exhibited a homology of nearly 100% both among themselves and with the originally discovered virus from 2005. Conclusion: Overall, our results indicate that HBoV is a significant pathogen that contributes to acute respiratory infection both on its own and during coinfection with other viruses. Keywords: Human bocavirus 1, Infant, Bronchiolitis, Pneumonia

Abstract licence: CC BY

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.